HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study.
Nesrin DilbazMurat KuloğluEkrem Cuneyt EvrenSalih Cihat PaltunRabia BiliciCemal Onur NoyanBurak KulaksizogluVahap KarabulutGokhan UmutBasak UnubolEnver UcbilekPublished in: Substance abuse : research and treatment (2023)
Although genotype 3 is the predominant genotype in the PWID population in Turkey, the prevalence of HCV genotype varied across the country. To eliminate HCV infection in the PWID, treatment and screening strategies that differ by genotype are essentially required. Especially identification of genotypes will be useful in developing individualized treatments and determining national prevention strategies.